Cue Health Inc.
HLTHDelisted- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001628945
Cue Health Inc. was delisted in 2024; its insiders filed their last Form 4 on Aug 27, 2024; 57 institutions reported holding it in 13F filings for Q1 2024, worth $10.5M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cue Health Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cue Health Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tarsadia Capital, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| TC GP, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| TCCS I, LP | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| Nvga I, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| TFC Manager, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| CP (HLTH), LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| Tarsadia Investments, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| TUP Investments, L.P. | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| T-Twelve Holdings, LLC | 10% Owner | 0Indirect | Aug 27, 2024 | 0 |
| Javed Aasim | Chief Financial Officer | 998,004 | May 21, 2024 | 0 |
| Sever Clint | Chief Executive Officer | 4,379,914 | Mar 27, 2024 | 0 |
| Pollard Randall E. | Chief Accounting Officer | 503,202 | Mar 7, 2024 | 0 |
| Achar Christopher K | Director | 1,616,722 | Mar 7, 2024 | 0 |
| Khattak Ayub K | President and CEO | 12,540,883 | Mar 7, 2024 | 0 |
| Reddy Rishi | Director | 72,573 | Feb 27, 2024 | 0 |
| Palsis Erica | General Counsel | 814,510 | Dec 7, 2023 | 0 |
| Bradford K Joanne | Director | 130,030 | Jun 7, 2023 | 0 |
| Martinez Maria | Director | 130,030 | Jun 7, 2023 | 0 |
| Jain Sachin H. | Director | 153,661 | Jun 7, 2023 | 0 |
| Faig Carole T | Director | 130,030 | Jun 7, 2023 | 0 |
| Ghaim Joshua | Director | 179,307 | Jun 7, 2023 | 0 |
| Gallagher John E | Chief Financial Officer | 627,668 | Mar 6, 2023 | 0 |
| Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | 8,192,468 | Sep 30, 2021 | 0 |
| Decheng Capital Management III (Cayman), LLC | 10% Owner | 8,192,468 | Sep 30, 2021 | 0 |
| Sherpa Ventures Fund, LP | 10% Owner | 5,491,741Indirect | Sep 30, 2021 | 0 |
| Sherpa Ventures Fund GP, LLC | 10% Owner | 5,491,741Indirect | Sep 30, 2021 | 0 |
| SherpaVentures Fund II, LP | 10% Owner | 5,491,741Indirect | Sep 30, 2021 | 0 |
| SherpaVentures Fund II GP, LLC | 10% Owner | 5,491,741Indirect | Sep 30, 2021 | 0 |
| Maris William J | 10% Owner | 3,485,535 | Sep 30, 2021 | 0 |
| Section 32 Fund 2, LP | 10% Owner | 3,485,535 | Sep 30, 2021 | 0 |
| Section 32 GP 2, LLC | 10% Owner | 3,485,535 | Sep 30, 2021 | 0 |
| Cove Investors II, LLC | 10% Owner | 12,377,254Indirect | Sep 30, 2021 | 0 |
| Cove Investors I, LLC | 10% Owner | 12,377,254Indirect | Sep 30, 2021 | 0 |
| Day Kelly P. | 10% Owner | 12,377,254Indirect | Sep 30, 2021 | 0 |
| Cui Xiangmin | Director | 788,441Indirect | Sep 30, 2021 | 0 |
| Stanford Scott | Director, 10% Owner | 5,491,741Indirect | Sep 30, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 (view filing)8:07 PM ET | Aug 23 | 4 days | Tarsadia Capital, LLC and 8 others10% Owner | SSaleCommon stock, par value $0.00001 per share ("Common Stock") | −10.7M | $0.0001 | −$1.07K | −100.0%0 after | |
| Aug 27, 2024 (view filing)8:07 PM ET | Aug 23-27 | 4 days | Tarsadia Capital, LLC and 8 others10% Owner | SSale | −7.62M | $0.00 | $0 | −100.0%0 after | 3 lots |
| Dec 9, 2022 (view filing)8:32 PM ET | Dec 8 | 1 day | Sever ClintChief Product Officer | SSale | −29.3K | $3.02 | −$88.3K | −0.7%3.94M after | |
| Dec 7, 2022 (view filing)9:11 PM ET | Dec 6-7 | 1 day | Sever ClintChief Product Officer | SSale | −50.8K | $3.06 | −$155.7K | −1.3%3.94M after | 2 lots |
| Dec 1, 2022 (view filing)7:31 PM ET | Nov 30 | 1 day | Sever ClintChief Product Officer | SSale | −22.7K | $3.11 | −$70.7K | −0.6%3.95M after | |
| Nov 25, 2022 (view filing)6:07 PM ET | Nov 22-25 | 3 days | Sever ClintChief Product Officer | SSale | −57.3K | $2.54 | −$145.5K | −1.4%3.95M after | 3 lots |
| Nov 10, 2022 (view filing)9:03 PM ET | Nov 8-10 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.83 | −$306.1K | −2.0%3.95M after | 3 lots |
| Oct 27, 2022 (view filing)9:19 PM ET | Oct 25-27 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.61 | −$289.0K | −2.0%3.95M after | 3 lots |
| Oct 13, 2022 (view filing)8:03 PM ET | Oct 11-13 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.29 | −$262.9K | −2.0%3.95M after | 3 lots |
| Oct 3, 2022 (view filing)8:33 PM ET | Sep 30 | 3 days | Sever ClintChief Product Officer | SSale | −7.37K | $3.03 | −$22.3K | −0.2%3.95M after | |
| Sep 29, 2022 (view filing)7:15 PM ET | Sep 27-29 | 2 days | Sever ClintChief Product Officer | SSale | −72.6K | $3.00 | −$217.9K | −1.8%3.95M after | 3 lots |
| Sep 15, 2022 (view filing)9:51 PM ET | Sep 13-15 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.63 | −$290.1K | −2.0%3.98M after | 3 lots |
| Sep 1, 2022 (view filing)8:05 PM ET | Aug 30-Sep 1 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.34 | −$266.9K | −2.0%3.99M after | 3 lots |
| Aug 18, 2022 (view filing)6:53 PM ET | Aug 16-18 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $4.25 | −$339.6K | −2.0%3.99M after | 3 lots |
| Jul 21, 2022 (view filing)9:10 PM ET | Jul 19-21 | 2 days | Sever ClintChief Product Officer | SSale | −80.0K | $3.40 | −$271.9K | −2.0%3.99M after | 3 lots |